Attached files
| file | filename |
|---|---|
| EX-32 - CERTIFICATIONS - GENEREX BIOTECHNOLOGY CORP | gnbt73114exh32.htm |
| EX-31.1 - CERTIFICATION - GENEREX BIOTECHNOLOGY CORP | gnbt73114exh31_1.htm |
| EX-23.2 - EXHIBIT 23.2 - GENEREX BIOTECHNOLOGY CORP | gnbt73114exh23_2.htm |
| EX-23 - EXHIBIT 23.1 - GENEREX BIOTECHNOLOGY CORP | gnbt73114exh23_1.htm |
| EX-31.2 - CERTIFICATION - GENEREX BIOTECHNOLOGY CORP | gnbt73114exh31_2.htm |
| EXCEL - IDEA: XBRL DOCUMENT - GENEREX BIOTECHNOLOGY CORP | Financial_Report.xls |
| 10-K - YEAR END 7/31/14 FORM 10-K - GENEREX BIOTECHNOLOGY CORP | gnbt73114form10k.htm |
Exhibit 21
SUBSIDIARIES OF GENEREX BIOTECHNOLOGY CORPORATION
| Name | Place of Incorporation | |
| Generex Pharmaceuticals, Inc. | Ontario, Canada | |
| 1097346 Ontario Inc. | Ontario, Canada | |
| Generex (Bermuda), Inc. | Bermuda | |
| Antigen Express, Inc. | Delaware, USA | |
| Generex Pharmaceuticals (USA) LLC. | North Carolina, USA | |
All subsidiaries are 100% owned.
To the extent that any of the above-named subsidiaries have commenced business operations, such subsidiaries conduct business only under their respective corporate names except for Antigen Express, Inc., which also does business under the name Generex Oncology and Generex Infectious Diseases.
1097346 Ontario Inc., a Canadian corporation incorporated in Ontario, Canada, is a 100% owned subsidiary of Generex Pharmaceuticals, Inc.
| . |